Difluprednate 0.05% versus Prednisolone Acetate Post-Phacoemulsification for Inflammation and Pain: An Efficacy and Safety Clinical Trial

Difluprednate 0.05% versus Prednisolone Acetate Post-Phacoemulsification for Inflammation and Pain: An Efficacy and Safety Clinical Trial

Claudia Palacio-Pastrana,1 Eduardo Chávez-Mondragón,2 Abraham Soto-Gómez,3 Rubén Suárez-Velasco,4 Miguel Montes-Salcedo,5 Lourdes Fernández de Ortega,6 Linda Nasser-Nasser,7 Leopoldo Baiza-Durán,8 Oscar Olvera-Monta&nti...

Full description

Bibliographic Details
Main Authors: Palacio-Pastrana C, Chávez-Mondragón E, Soto-Gómez A, Suárez-Velasco R, Montes-Salcedo M, Fernández de Ortega L, Nasser-Nasser L, Baiza-Durán L, Olvera-Montaño O, Muñoz-Villegas P
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Clinical Ophthalmology
Subjects:
difluprednate
dose-reduction
cataract surgery
ophthalmic corticosteroids
Online Access:https://www.dovepress.com/difluprednate-005-versus-prednisolone-acetate-post-phacoemulsification-peer-reviewed-article-OPTH

Internet

https://www.dovepress.com/difluprednate-005-versus-prednisolone-acetate-post-phacoemulsification-peer-reviewed-article-OPTH

Similar Items